Controlling cardiac arrhythmias: To delay conduction or to prolong refractoriness Bramah N. Singh Antiarrhythmic Agents Pages: 671 - 674
Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents Paul J. SilverMary J. ConnellAlan M. Ezrin Antiarrhythmic Agents Pages: 675 - 682
Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles Keitaro HashimotoKozo WatanabeHarumi Mitsuhashi Antiarrhythmic Agents Pages: 683 - 689
Encainide Michael J. AntonaccioAllen W. GomollJeffrey E. Byrne Antiarrhythmic Agents Pages: 691 - 710
Berpidil: A pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemia R. MassinghamP. A. Van Zwieten Reviews Pages: 731 - 742
Some socioeconomic factors in the selection of blood pressure drugs in New Orleans, Louisiana F. Gilbert McMahonAndrew JohnsonWilliam Duncan Hypertension Pages: 753 - 755
Should the costs of development inhibit research into new antihypertensive drugs? J. I. S. Robertson Hypertension Pages: 757 - 759
Cost of antihypertensive treatment: A point of view from India Harinder K. BaliInder S. Anand Hypertension Pages: 761 - 765
Effects of pindolol and propranolol on blood lipids in hypertensive patients Oscar RománM. Eugenia PinoAngélica Valenzuela Hypertension Pages: 767 - 770
The vasopressor system in patients with heart failure due to idiopathic dilated cardiomyopathy-influence of the clinical stage of disease and of chronic drug treatment V. MitrovicJ. ThormannM. Schlepper Clinical Studies Pages: 771 - 778
Imaging of acute myocardial infarction by magnetic resonance tomography (MRT) using the paramagnetic relaxation substance gadolinium-DTPA Hermann W. EichstaedtRoland FelixHorst Schmutzler Clinical Studies Pages: 779 - 788